Skip to content

Effect of lavender in treatment of polycystic ovary syndrome

Comparative study of the effect of lavender versus metformin on polycystic ovary syndrome

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210915052488N1
Enrollment
68
Registered
2021-11-18
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: The drug is in the form of 500 mg capsules(One hundred grams of lavender is boiled in one liter of water to reach 100 milliliter The solution is then passed through

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Diagnosis of polycystic ovary syndrome by a gynecologist

Exclusion criteria

Exclusion criteria: Do not take drugs that lower blood pressure, blood fats and blood sugar No pregnancy or breastfeeding Do not take insulin sensitizers Do not take aspirin or other anticoagulants Do not take anti-prostaglandin drugs Do not take other herbal medicines at the same time for your disease No history of uncontrolled blood pressure, stroke, heart attack, cancer or heart attack, cardiovascular disease, liver, kidney and thyroid disorders, type 1 or 2 diabetes No smoking Do not take oral contraceptives

Design outcomes

Primary

MeasureTime frame
Check menstrual days. Timepoint: After three months of treatment in the luteal phase. Method of measurement: Day.

Secondary

MeasureTime frame
Measurement of serum Progesterone in the luteal phase. Timepoint: After three months of treatment in the luteal phase. Method of measurement: Measurement of serum progesterone in the luteal phase more than 3 Nanogram / milliliter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Reza Simaei

Kermanshah University of Medical Sciences

sreza.simaei@kums.ac.ir+98 51 3847 0500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026